FindTrial
Sign In

Association between adverse events and prognosis in postoperative adjuvant chemotherapy for colorectal cancer

Association between adverse events and prognosis in postoperative adjuvant chemotherapy for colorectal cancer - Association between adverse events and prognosis in postoperative adjuvant chemotherapy for colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000047961
Enrollment
4212
Registered
2022-06-06
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Sponsors

Japanese Foundation for Multidisciplinary Treatment of Cancer
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients enrolled in clinical studies conducted by JFMC in the past (No.33, 35, 37,38, 41), those who received postoperative chemotherapy will be the target population for analysis.

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Relapse-free survival Overall survival Adverse event Compliance—

Countries

Japan

Contacts

Public ContactYukari/Masaru Kawamura/Mutoh

Japanese Foundation for Multidisciplinary Treatment of Cancer Data Management Section/Statistical Analysis Section

jfmc-dc@jfmc.or.jp0356277594

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026